EA201001835A1 - Противовирусные соли - Google Patents
Противовирусные солиInfo
- Publication number
- EA201001835A1 EA201001835A1 EA201001835A EA201001835A EA201001835A1 EA 201001835 A1 EA201001835 A1 EA 201001835A1 EA 201001835 A EA201001835 A EA 201001835A EA 201001835 A EA201001835 A EA 201001835A EA 201001835 A1 EA201001835 A1 EA 201001835A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- salts
- treatment
- virus
- prr
- viruses
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Данное изобретение относится к противовирусным агентам, в частности к солям, пригодным для лечения инфекций, вызванных вирусами семейства Picomaviridae, такими как риновирус человека (ЧРВ), и способам их приготовления. Изобретение также относится к применению этих солей для лечения пикорнавирусных инфекций. Соли из данного изобретения особенно пригодны для лечения ЧРВ, однако нужно понять, что изобретение также применятся к другим вирусам из семейства пикорнавирусов.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5634108P | 2008-05-27 | 2008-05-27 | |
PCT/AU2009/000663 WO2009143571A1 (en) | 2008-05-27 | 2009-05-27 | Antiviral salts |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201001835A1 true EA201001835A1 (ru) | 2011-06-30 |
EA020455B1 EA020455B1 (ru) | 2014-11-28 |
Family
ID=41376478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201001835A EA020455B1 (ru) | 2008-05-27 | 2009-05-27 | Бис(дигидрофосфатная) соль 6-{2-[1-(6-метил-3-пиридазинил)-4-пиперидинил]этокси}-3-этокси-1,2-бензизоксазола (1:2), способ ее получения и ее применение в композиции и способе лечения или предотвращения пикорнавирусных инфекций |
Country Status (14)
Country | Link |
---|---|
US (2) | US8580791B2 (ru) |
EP (1) | EP2297141B1 (ru) |
JP (1) | JP5469662B2 (ru) |
KR (1) | KR20110019759A (ru) |
CN (1) | CN102046621B (ru) |
AU (1) | AU2009253738B2 (ru) |
BR (1) | BRPI0912038A2 (ru) |
CA (1) | CA2725618C (ru) |
CO (1) | CO6280534A2 (ru) |
EA (1) | EA020455B1 (ru) |
MX (1) | MX2010013019A (ru) |
NZ (1) | NZ590286A (ru) |
WO (1) | WO2009143571A1 (ru) |
ZA (1) | ZA201009284B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2647223T3 (es) * | 2010-04-15 | 2017-12-20 | Biota Scientific Management Pty Ltd | Vapendavir para el alivio de los síntomas del asma en un sujeto que tiene una infección por el VRH |
WO2011160191A1 (en) | 2010-06-25 | 2011-12-29 | Biota Scientific Management Pty Ltd | Compound for the treatment of enteroviruses |
CN102617462B (zh) * | 2012-02-28 | 2014-02-12 | 南京大学 | 特异性抑制肌肉微小核糖核酸的化合物及其合成方法和应用 |
CA2952627C (en) | 2014-06-20 | 2018-05-22 | Aviragen Therapeutics, Inc. | Anhydrous crystalline free base form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79215B (ru) | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
GB2162522B (en) | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
GB9026998D0 (en) | 1990-12-12 | 1991-01-30 | Glaxo Group Ltd | Medicaments |
US5514778A (en) * | 1993-07-01 | 1996-05-07 | Eli Lilly And Company | Anti-picornaviral agents |
US5693661A (en) * | 1995-06-07 | 1997-12-02 | Eli Lilly And Company | Anti-viral compounds |
US5545653A (en) * | 1995-06-07 | 1996-08-13 | Eli Lilly And Company | Anti-viral compounds |
US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
WO1998031363A1 (en) * | 1997-01-22 | 1998-07-23 | Eli Lilly And Company | Anti-viral compounds |
AU7715198A (en) * | 1997-06-04 | 1998-12-21 | Eli Lilly And Company | Anti-viral compounds |
HUP0102117A2 (hu) * | 1998-05-20 | 2001-12-28 | Eli Lilly And Co. | Imidazo[1,2-a]piridin-származékok és ezeket tartalmazó gyógyászati készítmények |
US6358971B1 (en) * | 1998-05-20 | 2002-03-19 | Eli Lilly And Company | Anti-viral compounds |
AUPR213700A0 (en) * | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
-
2009
- 2009-05-27 BR BRPI0912038A patent/BRPI0912038A2/pt not_active IP Right Cessation
- 2009-05-27 JP JP2011510782A patent/JP5469662B2/ja not_active Expired - Fee Related
- 2009-05-27 EP EP09753335.0A patent/EP2297141B1/en not_active Not-in-force
- 2009-05-27 CN CN200980120191.2A patent/CN102046621B/zh not_active Expired - Fee Related
- 2009-05-27 CA CA2725618A patent/CA2725618C/en not_active Expired - Fee Related
- 2009-05-27 US US12/994,633 patent/US8580791B2/en active Active
- 2009-05-27 NZ NZ590286A patent/NZ590286A/en not_active IP Right Cessation
- 2009-05-27 MX MX2010013019A patent/MX2010013019A/es active IP Right Grant
- 2009-05-27 AU AU2009253738A patent/AU2009253738B2/en not_active Ceased
- 2009-05-27 KR KR1020107029303A patent/KR20110019759A/ko not_active Application Discontinuation
- 2009-05-27 EA EA201001835A patent/EA020455B1/ru not_active IP Right Cessation
- 2009-05-27 WO PCT/AU2009/000663 patent/WO2009143571A1/en active Application Filing
-
2010
- 2010-11-25 CO CO10148308A patent/CO6280534A2/es not_active Application Discontinuation
- 2010-12-23 ZA ZA2010/09284A patent/ZA201009284B/en unknown
-
2013
- 2013-09-10 US US14/023,280 patent/US9206171B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20110144118A1 (en) | 2011-06-16 |
ZA201009284B (en) | 2012-06-27 |
US9206171B2 (en) | 2015-12-08 |
NZ590286A (en) | 2011-08-26 |
EP2297141A1 (en) | 2011-03-23 |
CN102046621B (zh) | 2014-11-12 |
US8580791B2 (en) | 2013-11-12 |
MX2010013019A (es) | 2011-03-21 |
CN102046621A (zh) | 2011-05-04 |
CA2725618C (en) | 2016-04-12 |
EP2297141B1 (en) | 2015-10-21 |
EP2297141A4 (en) | 2012-04-25 |
BRPI0912038A2 (pt) | 2017-06-20 |
JP5469662B2 (ja) | 2014-04-16 |
WO2009143571A1 (en) | 2009-12-03 |
AU2009253738A1 (en) | 2009-12-03 |
CA2725618A1 (en) | 2009-12-03 |
AU2009253738B2 (en) | 2012-12-13 |
US20140179710A1 (en) | 2014-06-26 |
CO6280534A2 (es) | 2011-05-20 |
KR20110019759A (ko) | 2011-02-28 |
EA020455B1 (ru) | 2014-11-28 |
JP2011520991A (ja) | 2011-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201270656A1 (ru) | Ингибиторы вируса гепатита с | |
EA201171208A1 (ru) | Ингибиторы вируса гепатита с | |
EA201101082A1 (ru) | Ингибиторы вируса гепатита с | |
EA200900298A1 (ru) | Ингибиторы вируса гепатита с | |
EA201100390A1 (ru) | Соединения для лечения гепатита с | |
EA201300495A1 (ru) | Противовирусные соединения | |
EA201390190A1 (ru) | Ингибиторы вируса гепатита с | |
EA201490015A1 (ru) | Композиции на основе дрожжей и способы лечения или профилактики инфекции, вызванной вирусом гепатита дельта | |
EA029939B8 (ru) | Человеческие связывающие молекулы, обладающие способностью нейтрализовывать вирус гриппа h3n2, и их применение | |
EA201001273A1 (ru) | Ингибиторы вируса гепатита с | |
ATE551343T1 (de) | Tetracyclische verbindungen zur behandlung von hepatitis c | |
EA201270622A1 (ru) | Ингибиторы вируса гепатита с | |
EA201491179A1 (ru) | 2',4'-дифтор-2'-метил замещенные нуклеозидные производные в качестве ингибиторов репликации рнк вируса гепатита с | |
DE602008004317D1 (de) | Verbindungen zur behandlung von hepatitis c | |
EA201390538A1 (ru) | Противовирусные соединения | |
EA201490654A1 (ru) | Новые ингибиторы вирусной репликации | |
EA201001275A1 (ru) | Конформационно-ограниченные бифенильные производные для применения в качестве ингибиторов вируса гепатита с | |
ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
EA201391152A1 (ru) | Ингибиторы вируса гепатита с | |
EA200901241A1 (ru) | Соединения для лечения гепатита с | |
EA201391685A1 (ru) | Ингибиторы вируса гепатита с | |
EA201370017A1 (ru) | Ингибиторы вируса гепатита с | |
EA201000277A1 (ru) | Соединения для лечения гепатита с | |
ATE505473T1 (de) | Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c | |
UY32715A (es) | Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |